BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CXCL2
,
Apoptosis
,
Breast Cancer
,
Pancreas
,
Human chorionic gonadotropin
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protein serine/threonine phosphatases
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic kidney cells with MAP4K4 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors.
Protein phosphatases and their targets: Comprehending the interactions in plant signaling pathways.
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Affinity-based profiling of endogenous phosphoprotein phosphatases by mass spectrometry.
Adaptation of protein phosphatases in Oryza sativa and Cucumis sativus to microcystins.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast…
Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant S…
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3)
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ